Core summary of product characteristics for human plasma-derived and recombinant coagulation factor IX products - Scientific guideline
Human medicines European public assessment report (EPAR): Mepsevii, vestronidase alfa, Date of authorisation: 23/08/2018, Revision: 8, Status: Authorised
Summary of opinion: Cresemba, 27/06/2024 Positive
Clinical investigation of recombinant and human plasma-derived factor IX products - Scientific guideline
Mandate, objectives and rules of procedure of the Scientific Advice Working Party (SAWP)
Clinical Trial Information System (CTIS) - Sponsor handbook
Paediatric investigation plan (PIP) - Key elements guidance
CTIS newsflash - 28 June 2024
Draft guideline on the conduct of efficacy studies for intramammary products for use in cattle
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 24-27 June 2024